Dhanwantary Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 6.60%
(FY 2022)
- Profit 331.22%
(FY 2022)
- Ebitda 121.37%
(FY 2022)
- Net Worth 22.80%
(FY 2022)
- Total Assets 17.45%
(FY 2022)
About Dhanwantary Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramrao Nandris and Dilip Bhamare serve as directors at the Company.
- CIN/LLPIN
U24110MH1988PTC049144
- Company No.
049144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1988
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dhanwantary Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramrao Nandris  | Director | 05-Jan-1994 | Current |
| Dilip Bhamare | Director | 05-Jan-1994 | Current |
Financial Performance and Corporate Structure Insights of Dhanwantary Laboratories.
Dhanwantary Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.6% increase. The company also saw a substantial improvement in profitability, with a 331.22% increase in profit. The company's net worth Soared by an impressive increase of 22.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanwantary Laboratories?
In 2019, Dhanwantary Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sitson India Private LimitedActive 25 years 8 monthsRamrao Nandris and Dilip Bhamare are mutual person
- Sitson Process Control Systems Private LimitedActive 29 years 5 months
Ramrao Nandris and Dilip Bhamare are mutual person
Sitaram Sugars And Allied Industries LimitedActive 25 years 8 monthsRamrao Nandris and Dilip Bhamare are mutual person
- Saikripa Paper And Board Mills Private LimitedActive 33 years 9 months
Ramrao Nandris and Dilip Bhamare are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhanwantary Laboratories?
Dhanwantary Laboratories has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanwantary Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantary Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
